27 Jun, 2016Trending Innovations on Scientist.com


So many innovations, so little time. To save you some searching, here’re this month’s top 8 innovation picks. Let’s keep the conversation going —…

Read More

11 Mar, 2016Top 8 Innovation Picks for February 2016


Let’s keep the conversation going — use hashtag #sparkofinnovation to join the conversation on Twitter and Facebook!

Read More

01 Feb, 2016Top 8 Innovation Picks for January 2016

25 Jun, 2013Animal Models: Mouse is King


Mice and rats are go-to animal models for research.  A recent report out of the European Union demonstrated the dominance of these rodents…

Read More

07 Mar, 2013How To Fight Rare Disease


Working on the Rare Disease Science Challenge has shown me that everybody wants to support rare disease in many different ways, which is…

Read More

06 Nov, 2012Science in Politics: Election for Research


The US presidential election will soon come to a close today and many Americans will have casted their vote for the candidate who…

Read More

01 Nov, 2012Drug Discovery: controlling the rising cost through outsourcing


Our latest infographic touches on a subject we care deeply about: the cost of drug discovery and the need for cost-effective research and…

Read More

30 Jul, 2012Cage-Free Chimps: Is the End of Chimpanzee Research Near?


Animal testing is critical to advancing science and learning more about disease, but what animals are effective? It’s safe to say that mice,…

Read More

19 Jun, 2012The Decline of STEM: Why American Students Are Avoiding STEM Professions


The 2011-2012 school year is over, so we decided the next infographic should take a look at how the sciences are faring at…

Read More

14 May, 2012Buying Innovation: A Look at Pharmaceutical Mergers and Acquisitions


We’ve looked at what happens to a drug when a patent expires, but what happens to the patent owner? As patents have expired and many blockbuster drugs become generic, pharmaceutical companies have looked to new drugs and innovations to replace the lost income. Getting a drug through regulatory hurdles, such as clinical trials and safety testing, is difficult and millions of dollars can be lost from an unexpected failure. As many patents have expired and only a few drugs have replaced them in the past decade, pharmaceutical companies have looked to mergers and acquisitions for new products and drugs in an effort to buy innovation.

Read More